Ribbon-cutting event marks official start to R&D collaboration with Colorado State University
Tags: Research & Development
Zoetis is the animal health partner in a new five-year collaboration of public and private partners drawing on expertise in human and veterinary medicine taking aim at innovative vaccine solutions to control infectious diseases caused by bacterial pathogens.
Zoetis and Colorado State University (CSU) signed an agreement to establish a research lab that will explore the livestock immune system and target new immunotherapies – paving the way for new alternatives to antibiotics in food-producing animals.
Learn about scientific insights into the biology of skin allergy conditions in dogs from Dr. Andrea Gonzales of Zoetis
In this Innovation at Zoetis podcast, learn how genetic testing is helping farmers improve the health and performance of their herds, and the profitability and sustainability of their farms.
Up to 20 percent of food production animals are lost to disease annually with an associated cost of $120 billion from 1995 to 2008, according to the World Organisation for Animal Health (OIE). Preventing and controlling infectious diseases is important to protect animal and human health; to help assure a safe, sustainable supply of animal protein; and to safeguard the livelihoods of farmers.
Zoetis mobilizes response to outbreaks of infectious diseases through the its newly created Center for Transboundary and Emerging Diseases.
Dr. Scott A. Brown is vice president of External Innovation, Veterinary Medicine Research & Development at Zoetis. Here he shares his thoughts about the human and animal health connection.
Dr. Mahesh Kumar, Vice President, Global Biological Research and Development at Zoetis shares his insights on taking a One Health approach to combating emerging infectious diseases.
New infectious diseases and new subtypes of ever-present diseases are constantly emerging. These diseases can affect animals and people alike. Zoetis is at the forefront of the battle to combat bacteria and viruses threatening animal health.
The Zoetis joint venture in Jilin, China announced on August 27 the launch of Rui Lan An™, a specialized vaccine to help control porcine reproductive and respiratory syndrome (PRRS).
Zoetis has created a new network to identify and quickly address emerging infectious diseases in livestock and companion animals, and enhance the ability to rapidly respond and help control them.
Zoetis is proud to be the sole animal health company participant in PROHEALTH, a consortium of 22 research partners from 11 European countries coordinated by Newcastle University.
Modern veterinary medicine is quickly taking root in the People’s Republic of China.
Zoetis marked the completion of a 19,000-square-foot, three-story expansion at its manufacturing site in Lincoln, Nebraska.
Zoetis has entered into a collaboration with The Roslin Institute at the University of Edinburgh, United Kingdom, and the Biotechnology and Biological Sciences Research Council (BBSRC)
This month, Zoetis launched EnlightTM, a new online, comprehensive management tool designed to help dairy producers who own Holstein cattle more efficiently manage herd genetics.
Zoetis (formerly Pfizer Animal Health) and The Hippolia Foundation formed a strategic partnership in January 2012 to advance equine health through research and educational programs.
Dr. Catherine Knupp, executive vice president and president of Research and Development at Zoetis, shares her insights on the value of innovation to both animal and human health.